Home > Press > NanoInk Launches NanoBioDiscovery Division: New Division Will Focus on Novel Technologies for Biomarker and Drug Discovery
Abstract:
NanoInk, Inc., one of the world's leading nanotechnology enterprises, announced today the launch of its NanoBioDiscovery Division. The new division will utilize Dip Pen Nanolithography® nanofabrication techniques, in combination with proprietary detection systems, to produce uniquely sensitive assays for protein discovery and identification. Femtofluidics handling of samples and reagents with these systems will help provide key benefits for users, including enhanced reaction kinetics and assay cost savings.
Bruce Dudzik, NanoInk's Senior Director for Business Development, is leading the new unit. He summarized the division's customer benefits by saying, "If you're working in drug discovery, our company can help you find new drug targets that were previously out of reach and help identify compound safety issues earlier in the research process, so you save both time and money."
In addition, Mr. Dudzik emphasized that the new division will be accessible to customers of all sizes. "If acquisition costs and training are a problem," he said, "our contract research group can give you great results and invaluable experience with our system."
James M. Hussey, CEO of NanoInk, added these thoughts, "NanoInk is committed to developing applications for Nanofabrication and partnering to find solutions for the challenges associated with Life Science Research."
####
About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. Using the Dip Pen Nanolithography® patented and proprietary nanofabrication technology, scientists are enabled to rapidly and easily create nanoscale structures from a wide variety of materials. This low cost, easy to use and scalable technique brings sophisticated nanofabrication to the laboratory desktop. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 140 patents and applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, University of Strathclyde, University of Liverpool, California Institute of Technology and the University of Illinois at Urbana-Champaign.
For more information, please click here
Contacts:
David Gutierrez
Dresner Corporate Services
312-780-7204
Jennifer Jameson
Dresner Corporate Services
312-780-7241
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Openings/New facilities/Groundbreaking/Expansion
OCSiAl expands its graphene nanotube production capacities to Europe June 17th, 2022
GLOBALFOUNDRIES Moves Corporate Headquarters to its Most Advanced Semiconductor Manufacturing Facility in New York April 27th, 2021
Oxford Instruments Plasma Technology relocates to advanced manufacturing facility: Move driven by exceptional business growth February 12th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Printing/Lithography/Inkjet/Inks/Bio-printing/Dyes
Presenting: Ultrasound-based printing of 3D materials—potentially inside the body December 8th, 2023
Simple ballpoint pen can write custom LEDs August 11th, 2023
Disposable electronics on a simple sheet of paper October 7th, 2022
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||